Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review

Ocular Surface

Volumn 14, Issue 2, 2016, Pages 144-167

  McDonald, Marguerite ^a   Patel, Dipen A ^b   Keith, Michael S ^c   Snedecor, Sonya J ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b PHARMERIT INTERNATIONAL   (United States)

^c SHIRE   (United States)

Author keywords

Burden of disease; cost; dry eye disease; quality of life; systematic literature review

Indexed keywords

ARTICLE; CHINA; DRY EYE; ECONOMIC ASPECT; FRANCE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; ITALY; JAPAN; PRODUCTIVITY; QUALITY OF LIFE; SPAIN; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; ASIA; COST OF ILLNESS; EUROPE; NORTH AMERICA;

ASIA; COST OF ILLNESS; DRY EYE SYNDROMES; EUROPE; HEALTH CARE COSTS; HUMANS; NORTH AMERICA; QUALITY OF LIFE;

EID: 84963957924     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2015.11.002     Document Type: Review

References (68)

1. P.D. O'Brien, and L.M. Collum Dry eye: diagnosis and current treatment strategies Curr Allergy Asthma Rep 4 2004 314 319
2. (No authors listed). The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2007 75 92
3. S. Shimmura, J. Shimazaki, and K. Tsubota Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye Cornea 18 1999 408 411
4. (No authors listed). The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2007 93 107
5. G.C. Brown, M.M. Brown, H.C. Brown, and et al. Topical cyclosporine (Restasis) cost-utility analysis Evidence-Based Ophthalmology 10 2009 166 167
6. Y. Mizuno, M. Yamada, and C. Shigeyasu Annual direct cost of dry eye in Japan Clin Ophthalmol 6 2012 755 760
7. P. Reddy, O. Grad, and K. Rajagopalan The economic burden of dry eye: a conceptual framework and preliminary assessment Cornea 23 2004 751 761
8. J. Yu, C.V. Asche, and C.J. Fairchild The economic burden of dry eye disease in the United States: a decision tree analysis Cornea 30 2011 379 387
9. J.P. Clegg, J.F. Guest, A. Lehman, and A.F. Smith The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists Ophthalmic Epidemiol 13 2006 263 274
10. D.A. Schaumberg, R. Dana, J.E. Buring, and D.A. Sullivan Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies Arch Ophthalmol 127 2009 763 768
11. D.A. Schaumberg, D.A. Sullivan, J.E. Buring, and M.R. Dana Prevalence of dry eye syndrome among US women Am J Ophthalmol 136 2003 318 326
12. R.G. Fiscella, J.T. Lee, J.G. Walt, and T.D. Killian Utilization characteristics of topical cyclosporine and punctal plugs in a managed care database Am J Manag Care 14 2008 S107 S112
13. A. Galor, D.D. Zheng, K.L. Arheart, and et al. Dry eye medication use and expenditures: data from the Medical Expenditure Panel Survey 2001 to 2006 Cornea 31 2012 1403 1407
14. M.D. Dalzell Dry eye: prevalence, utilization, and economic implications Manag Care 12 2003 9 13
15. W.D. Cross, L.F. Lay Jr., J.G. Walt, and C.M. Kozma Clinical and economic implications of topical cyclosporin A for the treatment of dry eye Manag Care Interface 15 2002 44 49
16. J.D. Hirsch Considerations in the pharmacoeconomics of dry eye Manag Care 12 2003 33 38
17. V.D. Patel, J.H. Watanabe, J.A. Strauss, and A.T. Dubey Work productivity loss in patients with dry eye disease: an online survey Curr Med Res Opin 27 2011 1041 1048
18. M. Yamada, Y. Mizuno, and C. Shigeyasu Impact of dry eye on work productivity Clinicoecon Outcomes Res 4 2012 307 312
19. P. Buchholz, C.S. Steeds, L.S. Stern, and et al. Utility assessment to measure the impact of dry eye disease Ocul Surf 4 2006 155 161
20. A. Denoyer, G. Rabut, and C. Baudouin Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease Ophthalmology 119 2012 1811 1818
21. N. Deschamps, X. Ricaud, G. Rabut, and et al. The impact of dry eye disease on visual performance while driving Am J Ophthalmol 156 2013 184 189.e3
22. M.R. García-Catalán, E. Jerez-Olivera, and J.M. Benítez-Del-Castillo-Sánchez [Dry eye and quality of life] Arch Soc Esp Oftalmol 84 2009 451 458 Spanish
23. C. Jacobi, A. Jacobi, F.E. Kruse, and C. Cursiefen Tear film osmolarity measurements in dry eye disease using electrical impedance technology Cornea 30 2011 1289 1292
24. R. Belenguer, M. Ramos-Casals, P. Brito-Zerón, and et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome Clin Exp Rheumatol 23 2005 351 356
25. S.J. Bowman, D.A. Booth, R.G. Platts UK Sjögren's Interest Group Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool Rheumatology (Oxford 43 2004 758 764
26. K.L. Hackett, J.L. Newton, J. Frith, and et al. Impaired functional status in primary Sjögren's syndrome Arthritis Care Res (Hoboken) 64 2012 1760 1764
27. C. Iannuccelli, F.R. Spinelli, M.P. Guzzo, and et al. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol 30 2012 117 121
28. J. Rostron, S. Rogers, L. Longman, and et al. Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study Gerodontology 19 2002 53 59
29. H.A. Stevenson, M.E. Jones, J.L. Rostron, and et al. UK patients with primary Sjögren's syndrome are at increased risk from clinical depression Gerodontology 21 2004 141 145
30. C.P. Mavragani, and H.M. Moutsopoulos Conventional therapy of Sjogren's syndrome Clin Rev Allergy Immunol 32 2007 284 291
31. S.C. Pflugfelder Differential diagnosis of dry eye conditions Adv Dent Res 10 1996 9 12
32. C. Vitali, S. Bombardieri, H.M. Moutsopoulos, et al. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study Ann Rheum Dis 55 1996 116 121
33. K.K. Nichols, G.L. Mitchell, and K. Zadnik Performance and repeatability of the NEI-VFQ-25 in patients with dry eye Cornea 21 2002 578 583
34. C.J. Fairchild, R.L. Chalmers, and C.G. Begley Clinically important difference in dry eye: change in IDEEL-symptom bother Optom Vis Sci 85 2008 699 707
35. L. Abetz, K. Rajagopalan, P. Mertzanis, et al. Impact of Dry Eye on Everyday Life (IDEEL) Study Group Development and validation of the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients Health Qual Life Outcomes 9 2011 111
36. K. Rajagopalan, L. Abetz, P. Mertzanis, and et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye Value Health 8 2005 168 174
37. P. Mertzanis, L. Abetz, K. Rajagopalan, and et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample Invest Ophthalmol Vis Sci 46 2005 46 50
38. R.M. Schiffman, J.G. Walt, G. Jacobsen, and et al. Utility assessment among patients with dry eye disease Ophthalmology 110 2003 1412 1419
39. B. Miljanović, R. Dana, D.A. Sullivan, and D.A. Schaumberg Impact of dry eye syndrome on vision-related quality of life Am J Ophthalmol 143 2007 409 415
40. R.M. Sullivan, J.M. Cermak, A.S. Papas, and et al. Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome Adv Exp Med Biol 506 2002 1183 1188
41. Y. Mizuno, M. Yamada, Y. Miyake, and Dry Eye Survey Group of the National Hospital Organization of Japan Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome Jpn J Ophthalmol 54 2010 259 265
42. P.-Y. Lin, S.-Y. Tsai, C.-Y. Cheng, and et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study Ophthalmology 110 2003 1096 1101
43. A.J. Lee, J. Lee, S.-M. Saw, and et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia Br J Ophthalmol 86 2002 1347 1351
44. M.M. Brown, G.C. Brown, H.C. Brown, and et al. Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome Arch Ophthalmol 127 2009 146 152
45. J.L. Gayton Etiology, prevalence, and treatment of dry eye disease Clin Ophthalmol 3 2009 405 412
46. H. Hashemi, M. Khabazkhoob, A. Kheirkhah, and et al. Prevalence of dry eye syndrome in an adult population Clin Experiment Ophthalmol 42 2014 242 248
47. K. Matsui, H. Suzuki, C. Eoyang, and et al. Japan: portfolio strategy. Womenomics 3.0: the time is now 2010 The Goldman Sachs Group, Inc New York, NY Available at: http://www.goldmansachs.com/our-thinking/investing-in-women/bios-pdfs/womenomics3-the-time-is-now-pdf.pdf Accessed June 17, 2015
48. K.W. Kim, S.B. Han, E.R. Han, and et al. Association between depression and dry eye disease in an elderly population Invest Ophthalmol Vis Sci 52 2011 7954 7958
49. A. Labbé, Y.X. Wang, Y. Jie, and et al. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study Br J Ophthalmol 97 2013 1399 1403
50. K.K. Nichols The international workshop on meibomian gland dysfunction: introduction Invest Ophthalmol Vis Sci 52 2011 1917 1921
51. B.D. Sullivan, L.A. Crews, E.M. Messmer, and et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications Acta Ophthalmol 92 2014 161 166
52. E. Viso, M.T. Rodriguez-Ares, D. Abelenda, and et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain Invest Ophthalmol Vis Sci 53 2012 2601 2606
53. Lee JT, Teale CW. Development of an economic model to assess costs and outcomes associated with dry eye disease (poster). Poster presented at: 2000 Spring Practice and Research Forum of the American College of Clinical Pharmacy; April 2-5, 2000; Monterey, CA
54. J. Hirsch, C. Kozma, A. Woicik, and B. Reis Economic and quality of life impact on dry eye symptoms: a Sjögren's patient survey (abstract) Invest Ophthalmol Vis Sci 39 1998 S65. ARVO Abstract
55. J.E. Ware, K.K. Snow, M. Kosinski, and B. Gandek SF-36 Health Survey: manual and interpretation guide 1993 The Health Institute, New England Medical Center Boston, MA
56. C.G. Begley, R.L. Chalmers, L. Abetz, and et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity Invest Ophthalmol Vis Sci 44 2003 4753 4761
57. R. Seror, P. Ravaud, S.J. Bowman, et al. EULAR Sjögren's Task Force EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome Ann Rheum Dis 69 2010 1103 1109
58. R. Seror, P. Ravaud, X. Mariette, et al. EULAR Sjögren's Task Force EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome Ann Rheum Dis 70 2011 968 972
59. R.M. Schiffman, M.D. Christianson, G. Jacobsen, and et al. Reliability and validity of the Ocular Surface Disease Index Arch Ophthalmol 118 2000 615 621
60. C.M. Mangione, P.P. Lee, P.R. Gutierrez, et al. National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058
61. L. Maska, J. Anderson, and K. Michaud Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL) Arthritis Care Res (Hoboken) 63 suppl 11 2011 S4 S13
62. The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
63. M.W. Johns A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale Sleep 14 1991 540 545
64. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
65. S.M. Skevington, M. Lotfy, K.A. O'Connell WHOQOL Group The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group Qual Life Res 13 2004 299 310
66. R. Whelan-Goodinson, J. Ponsford, and M. Schonberger Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV J Affect Disord 114 2009 94 102
67. W.W.K. Zung A rating instrument for anxiety disorders Psychosomatics 12 1971 371 379
68. W.W.K. Zung A self-rating depression scale Arch Gen Psychiatry 12 1965 63 70